Page 1 | Search Results | Hematology, ASH Education Program

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Navigating the nexus of MRD and novel agents in ALL

Anjali S. Advani, Edward A. Copelan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 9–16.

https://doi.org/10.1182/hematology.2019000008

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Mechanisms of and approaches to overcoming resistance to immunotherapy

Liora Schultz, Rebecca Gardner

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 226–232.

https://doi.org/10.1182/hematology.2019000018

Published: 2019

Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Tania Jain, Mark R. Litzow

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 25–34.

https://doi.org/10.1182/asheducation-2018.1.25

Published: 2018

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Progress in adult ALL: incorporation of new agents to frontline treatment

Jessica Leonard, Wendy Stock

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 28–36.

https://doi.org/10.1182/asheducation-2017.1.28

Published: 2017

Journal Articles

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Lewis B. Silverman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 259–264.

https://doi.org/10.1182/asheducation-2017.1.259

Published: 2017

Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.

https://doi.org/10.1182/asheducation-2016.1.567

Published: 2016

Journal Articles

Advances in therapies for non-Hodgkin lymphoma in children

Rachel Kobos, William Terry

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 522–528.

https://doi.org/10.1182/asheducation.V2015.1.522.3916185

Published: 2015

Journal Articles

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Dieter Hoelzer

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 243–249.

https://doi.org/10.1182/asheducation-2011.1.243

Published: 2011

NARROW

Navigating the nexus of MRD and novel agents in ALL

Moving immunotherapy into the front line in ALL

Mechanisms of and approaches to overcoming resistance to immunotherapy

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Antibody-based therapies in patients with acute lymphoblastic leukemia

Progress in adult ALL: incorporation of new agents to frontline treatment

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Advances in therapies for non-Hodgkin lymphoma in children

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only